CIFXIT CLAV

CIFXIT CLAV
Cefixime 200 mg &

Potassium Clavulanate 125 mg Tablets**

A broad-spectrum cephalosporin antibiotic combined with a potent ?-lactamase inhibitor for enhanced antibacterial activity.

BENEFITS:

? Powerful action against resistant bacterial strains
? Broad coverage of gram-positive & gram-negative infections
? Reduces treatment failures caused by ?-lactamase?producing organisms
? Effective for recurrent and complicated infections
? High clinical success rate with better outcomes

USAGE:

One tablet twice daily
or as directed by the physician.

MECHANISM OF ACTION:

Cefixime: Inhibits bacterial cell wall synthesis, producing strong bactericidal action.

Potassium Clavulanate: Blocks ?-lactamase enzymes, protecting cefixime from degradation and boosting its activity.

Together, they deliver enhanced broad-spectrum antibacterial protection.

INDICATIONS (BEST 4):

Respiratory tract infections

Urinary tract infections (UTIs)

Skin & soft tissue infections

Resistant or recurrent bacterial infections